NextConsensus · specimen work product
Cardiorenal Access Ratification Memo (Redacted Excerpt)
Forwarding copy for buyer review. Identifiers are redacted; decision structure and safeguards are preserved.
1) Concrete problem framing
Prior-authorization criteria in [payer region A] are still aligned to legacy evidence and are now misaligned with the current risk profile in [high-risk cohort]. Delay is visible as slower appropriate starts and avoidable acute utilization leakage.
2) Explicit recommendation
Approve a bounded local override for exactly three accounts. Apply updated entry criteria from the governance packet and leave all non-pilot account criteria unchanged during the window.
3) Decision-owner path
Owner initiates packet sign-off through Brand Strategy → HEOR → Medical/MLR → Legal → Procurement. Activation requires written approval from Medical/MLR and Legal plus executed pilot procurement terms.
4) Safeguards and rollback
Safety and utilization guardrails are reviewed weekly. If any guardrail breaches twice in a rolling 14-day period, pilot logic is paused within one business day and reverts to legacy criteria until committee re-review.
5) What changes next week vs later
Next week: finalize signers, lock pilot accounts, run checklist training, and adjudicate first cases.
Later (day 45–120): review leakage, cycle-time, and safety outcomes to scale, narrow, or sunset.
Source page: nextconsensus.com/work-product/#specimen-decision-memo